Chaouki Khoury
Neurology with Special Qualifications in Child Neurology · Atlanta, GANPI 1831223049
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $724,144 of the $978,323 with a category attached, or 74.0%. 60 manufacturers reported payments, led by AbbVie at 56.9% of the total. 2025 is the largest year on record at $249,711, more than ten times the $1,883 reported in 2019. Among neurology with special qualifications in child neurology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,236 payments — averaging $437.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$557K
- Lundbeck LLC$244K
- Biohaven Pharmaceuticals, Inc.$61K
- Biohaven Pharmaceutical Holding Company Ltd.$32K
- Impel Pharmaceuticals Inc.$27K
- Axsome Therapeutics, Inc.$24K
- plus $34K from 54 others
Across 13 payments — averaging $2179.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- H. Lundbeck A S$28K
What the payments were for
- Consulting fees$102,58710%
- Speaking & faculty fees$724,14474%
- Travel & lodging$108,44811%
- Food & beverage$43,1374%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$429,794
- QULIPTA$320,264
- VYEPTI$235,223
- NURTEC ODT$95,123
- Trudhesa$31,614
- Symbravo$15,301
- TOSYMRA$2,275
- MIGRANAL$2,118
- ZEMBRACE SYMTOUCH$1,267
- AJOVY$628
- EMGALITY$449
- REYVOW$238
- BOTOX$235
- Tosymra Sumatriptan Nasal Spray$202
- QUDEXY XR Topiramate Extended Release Capsules$202
- Zembrace SymTouch Sumatriptan Injection$202
- DIACOMIT$158
- TYSABRI$150
- DYSPORT$144
- Omnia$130
How this compares
$978,323 in reported general payments places this provider in the 95th percentile of 41 neurology with special qualifications in child neurology providers in Georgia.
See all neurology with special qualifications in child neurology providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 15 | $24,348 |
| QuliptaAtogepant | 11 | $11,301 |
| Vilazodone Hcl | 13 | $1,311 |
| Duloxetine Hcl | 26 | $604 |
| Divalproex Sodium | 13 | $536 |
| Doxepin Hcl | 13 | $510 |
| Ramelteon | 11 | $275 |
| Cyclobenzaprine Hcl | 13 | $100 |
| Clonazepam | 13 | $49 |
| Sumatriptan Succinate | 12 | $49 |
| Trazodone Hcl | 12 | $20 |
| Famotidine | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $556,797 | $35,64926 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 41 neurology with special qualifications in child neurology providers in Georgia.
Other neurology with special qualifications in child neurology in Atlanta
- Han PhanAtlanta$44K
- Raymond ChengAtlanta$40K
- Sonam BhallaAtlanta$23K
- Cherise FrazierAtlanta$9K
- Howard SchubAtlanta$7K
- Ton de GrauwAtlanta$4K
- Jamika Hallman-CooperAtlanta$2K
- Moira BlackAtlanta$1K
- Jenny LinAtlanta$1K
- Kishore VedalaAtlanta$733
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.